Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NS-HGlio

K-Number: K221738 · 2022-09-27

ApplicantNeosoma, Inc.
Decision Date2022-09-27
Product CodeQIH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

NS-HGlio is a medical device manufactured by Neosoma, Inc.. It received FDA 510(k) clearance on 2022-09-27 under approval number K221738. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NS-HGlio?

NS-HGlio is a medical device that received FDA 510(k) clearance on 2022-09-27. It is manufactured by Neosoma, Inc.. The 510(k) number is K221738.

When was NS-HGlio approved by the FDA?

NS-HGlio received FDA 510(k) clearance on 2022-09-27, under approval number K221738.

What company makes NS-HGlio?

NS-HGlio is manufactured by Neosoma, Inc..

What is the FDA product code for NS-HGlio?

The FDA product code for NS-HGlio is QIH.

Other Devices by Neosoma, Inc.

K252922Neosoma Brain Mets

Related Devices (Code: QIH)

K191647QLAB Advanced Quantification SoftwarePhilips Health Care K191171EchoGo CoreUltromics, Ltd. K201195syngo.via MI Workflows, syngo MBFSiemens Medical Solutions USA, Inc. K202013WRDensity by Whiterabbit.aiWhiterabbit.Ai, Inc. K202546LVivo SeamlessDia Imaging Analysis, Ltd. K193283AI-Rad Companion Prostate MRSiemens Medical Solutions USA, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑